Autograft and allograft bone chips interbody fusion for spondylodiscitis: Surgery outcomes.
ASIA
JOABPEQ
Modified interbody fusion
Spondylodiscitis
surgery
Journal
Caspian journal of internal medicine
ISSN: 2008-6164
Titre abrégé: Caspian J Intern Med
Pays: Iran
ID NLM: 101523876
Informations de publication
Date de publication:
2023
2023
Historique:
received:
22
02
2022
revised:
26
03
2022
accepted:
03
04
2022
entrez:
6
2
2023
pubmed:
7
2
2023
medline:
7
2
2023
Statut:
ppublish
Résumé
Spondylodiscitis is a rare illness and serious complication of the vertebral column. The suitable type of surgery is debatable for these patients. This study describes a series of cases that are treated with modified interbody fusion for the treatment of spondylodiscitis by combining allograft and autograft bone chips with posterior segmental fusion. This was a retrospective study. The clinical deficit was evaluated with ASIA, VAS, and JOABPEQ scores before and after surgery. Radiological parameters were assessed with local kyphosis angle (degree), segmental height correction, and loss of correction. Post-operative bone union was evaluated as suggested by Tan et al. The mean age of patients (n=34) was 52.3(SD=13.6) years and 67.6% were males. The mean follow-up duration was 25.8 (2.3) months. In the last follow-up, VAS back pain 4.9(0.77), VAS leg pain 4.6(0.78), JOABPEQ low back pain 68.1 (9.3), JOABPEQ lumbar function 81.3 (8.9), and JOABPEQ walking ability 72.8 (8.3) shows a significant difference when compared with preoperative scores. According to ASIA grading, none of the patients deteriorated neurologically (all p<0.0001). The average segmental height correction and loss of correction were observed 7.5(3.7) % and -1.8(3.6) %, respectively, indicating improvements in the patients. A high union fusion rate (82.4%) was observed in the last follow-up. This modified method can be a safe and effective technique for surgical intervention in patients with spondylodiscitis.
Sections du résumé
Background
UNASSIGNED
Spondylodiscitis is a rare illness and serious complication of the vertebral column. The suitable type of surgery is debatable for these patients. This study describes a series of cases that are treated with modified interbody fusion for the treatment of spondylodiscitis by combining allograft and autograft bone chips with posterior segmental fusion.
Methods
UNASSIGNED
This was a retrospective study. The clinical deficit was evaluated with ASIA, VAS, and JOABPEQ scores before and after surgery. Radiological parameters were assessed with local kyphosis angle (degree), segmental height correction, and loss of correction. Post-operative bone union was evaluated as suggested by Tan et al.
Results
UNASSIGNED
The mean age of patients (n=34) was 52.3(SD=13.6) years and 67.6% were males. The mean follow-up duration was 25.8 (2.3) months. In the last follow-up, VAS back pain 4.9(0.77), VAS leg pain 4.6(0.78), JOABPEQ low back pain 68.1 (9.3), JOABPEQ lumbar function 81.3 (8.9), and JOABPEQ walking ability 72.8 (8.3) shows a significant difference when compared with preoperative scores. According to ASIA grading, none of the patients deteriorated neurologically (all p<0.0001). The average segmental height correction and loss of correction were observed 7.5(3.7) % and -1.8(3.6) %, respectively, indicating improvements in the patients. A high union fusion rate (82.4%) was observed in the last follow-up.
Conclusion
UNASSIGNED
This modified method can be a safe and effective technique for surgical intervention in patients with spondylodiscitis.
Identifiants
pubmed: 36741477
doi: 10.22088/cjim.14.1.133
pmc: PMC9878893
doi:
Types de publication
Journal Article
Langues
eng
Pagination
133-137Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Asian Spine J. 2011 Sep;5(3):155-61
pubmed: 21892387
Eur Spine J. 2016 Apr;25(4):983-99
pubmed: 26585975
Int J Med Microbiol. 2002 Jul;292(2):107-13
pubmed: 12195733
Eur Spine J. 2007 Nov;16(11):1875-81
pubmed: 17497188
Clin Infect Dis. 2002 May 15;34(10):1342-50
pubmed: 11981730
J Clin Neurosci. 2017 Oct;44:23-29
pubmed: 28736113
Acta Neurochir (Wien). 2016 Oct;158(10):1851-7
pubmed: 27510825
Neurosurg Focus. 2004 Dec 15;17(6):E7
pubmed: 15636577
J Spinal Cord Med. 2011 Nov;34(6):535-46
pubmed: 22330108
Spine (Phila Pa 1976). 2012 Dec 1;37(25):E1572-9
pubmed: 22996263
Clin Neurol Neurosurg. 2020 Dec;199:106259
pubmed: 33031986
J Orthop Sci. 2012 Sep;17(5):521-5
pubmed: 22821408
SICOT J. 2020;6:5
pubmed: 32057290
Dtsch Arztebl Int. 2017 Dec 25;114(51-52):875-882
pubmed: 29321098
J Neurosurg Spine. 2008 May;8(5):405-12
pubmed: 18447685